Strut Health Review: Cost & Is It Legit?

Strut Health is an online telehealth company that sells compounded GLP-1 medication on a monthly subscription. Weight loss is one line among several: it also sells hair, skin, sexual health, peptide and testosterone treatments.

Here is how it goes. You fill in an online visit, which takes about 5 minutes. "A U.S. board-certified physician reviews it and decides if a prescription is right for you." If the answer is yes, the medication ships to your door. The FAQ says it "typically arrives within 2 business days." Refills continue on the same subscription, with free follow-up care.

The menu has four products, all compounded. Semaglutide comes as a weekly injection or as an oral lozenge. Tirzepatide comes as an injection or as a daily oral tablet. There is no brand-name option. Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved. For what these drugs are, read our pages on compounded semaglutide and compounded tirzepatide.

Strut Health ships to every US state except Arkansas, and some medications are not available in some states.

Strut Health starts at $99 a month for oral semaglutide, all in. That price covers the medication, the physician consultations and the shipping, with no other fee.

Here is each product on the monthly auto-refill plan. Oral semaglutide is $99 a month. Injectable semaglutide is $129 a month. Injectable tirzepatide is $149 a month. The oral tirzepatide tablet is $199 a month. None of these is a promo rate, and each one held when we read the pages again.

There is nothing on top. The membership fee, the consultation fee and the shipping fee are each $0. The tirzepatide page says "No Hidden Fees – No Insurance Needed Free Follow-Ups – Free Shipping". Strut Health does not bill insurance. Its FAQ says it accepts all major credit cards, and that charges to HSA and FSA cards may be rejected by the card issuer. Three months of oral semaglutide total $297, with no fees added.

One catch on the tirzepatide injection. The page says the final price is set after the consultation. Treat $149 as the price until checkout shows you yours.

Prices have come down. The semaglutide injection fell from $149 to $129, and the tirzepatide injection from $199 to $149.

On month-to-month prices, Strut Health ranks 3 of the 20 compounded programs in its group. The median there is $168 a month. For scale, a pharmacy pays $871.12 for a Wegovy 1.7 mg pen package, effective September 23, 2026. That is an acquisition cost for the brand-name drug, not what a patient pays.

Strut Health is a real telehealth company with US-licensed physicians, clear prices and a working subscription. But it has an open FDA warning letter dated February 20, 2026, and it names no pharmacy.

The pharmacy is the gap. Strut Health names no compounding pharmacy on any page we read, and it does not state the pharmacy type. So there is nothing to match against the FDA register. That matters with a compounded drug, because the pharmacy makes the product itself.

The rest is plain. Each product page names the molecule and the form, and says the drug is compounded. The FAQ warns that a pickup at your own pharmacy "could be 3 to 4 times as expensive."

Strut Health publishes no public discount code on the pages we read. The discount it shows is the auto-refill plan. Each product page shows an auto-refill saving, from 13% to 21%, and the auto-refill price is the monthly price in the cost section. Oral semaglutide on auto-refill is $99 a month, the lowest entry price Strut Health shows.

The pages state no one-time price, so there is no higher rate to compare the saving against. The tirzepatide injection page also says the final price is set after the consultation. Codes posted on coupon sites are not on Strut Health's own pages. Check the total at checkout before you pay.

The care runs through an online visit and physician review, not scheduled video calls. You answer the intake questions, and a licensed physician decides whether a compounded GLP-1 fits you. Strut says it "works with a knowledgeable team of U.S.-licensed and board-certified physicians."

Follow-up care is free and included in the monthly price. The telemedicine consent says Strut "May require in-person follow-up before prescribing certain medications". The prescriber also sets the supply: the terms say a provider "will limit supply based upon state regulations".

The injectable tirzepatide has a gate. Its page says it is "Only available for patients that fail or cannot use other commercially available GLP-1 receptor agonist medications." So expect questions about what you have tried before.

Strut Health does not state how fast the physician reviews your visit, or whether it asks for labs.

Strut Health has an open FDA warning letter to Strut Health, LLC dba Strut, dated February 20, 2026. The subject is false and misleading claims and misbranding by a telehealth seller. The FDA reviewed the site in December 2025 and wrote that it "has observed that your website offers compounded drug products, including semaglutide and tirzepatide drug products."

The letter has no close-out. While it stays open, we do not link to Strut Health. There is no other open flag, and no letter names a pharmacy, though Strut Health names none.

The compounded drugs are not FDA approved. For side effects, doses and who should not take these drugs, read our pages on semaglutide side effects and tirzepatide side effects, which quote the FDA labels.

You can pause or cancel at any time by emailing care@struthealth.com. The FAQ says you can also change or delay an order in My Account, under the Orders and Subscriptions tab. The product pages say "Cancel anytime", and no page we read states a minimum term.

You are charged every 30 or 90 days, depending on your refill schedule. The product pages price a monthly supply, and the FAQ says a 90-day supply is offered for select products only. To stop the next refill, cancel at least 48 hours before the order goes to processing.

Refunds stop once the pharmacy has processed your order. After that point, a cancellation request gets no money back for that month. There is no money-back guarantee either.

So the trap is timing. If you want to stop, cancel well before the refill date, not on the day it ships.

Strut Health shows two short five-star testimonials, dated March 2026, on its home page and its how-it-works page. One praises the customer service on an NAD injection program; the other reads "Very quick and responsive customer service!" Neither mentions weight loss, and this site collects no independent reviews.

What you can check is the record and the terms. The FDA warning letter is open. Strut Health names no pharmacy. Before you pay, read the refund rule: there is no refund once the pharmacy has processed your order, so cancel at least 48 hours before processing. If you read reviews elsewhere, look for comments on refill timing and on the final tirzepatide price after the consultation.

Our score combines seven checks. Each one counts for a fixed share of the total, listed below. Commission is not an input.

• Price transparency: 10/10 (counts for 20% of the total score). Every fee is $0, every price is public and each one held on re-read.
• Cost and value: 9/10 (counts for 15% of the total score). Rank 3 of 20 on month-to-month prices, no fee load.
• Medication and pharmacy traceability: 5.8/10 (counts for 15% of the total score). No pharmacy named, no pharmacy type stated.
• Clinical access and oversight: 7.2/10 (counts for 15% of the total score). Named physicians and free follow-ups, but no wait time and no lab policy.
• Safety and enforcement: 8/10 (counts for 20% of the total score). The open FDA warning letter.
• Terms, commitment and refunds: 10/10 (counts for 10% of the total score). Cancel anytime, monthly billing, refund rule stated.
• Availability and fulfillment: 9.94/10 (counts for 5% of the total score). 49 states, free shipping and a stated delivery time.

Since our last check, 10 of the site's other pages changed. We rescored Strut Health on October 10. Two programs now charge less a month, so its rank fell from 2 to 3 and cost and value fell from 10 to 9. The total fell from 8.5 to 8.4, which moves it from Very good to Good. On October 16 its group grew to 20 programs; its rank holds at 3, and no score changed. The method is on our methodology page.